ISIS Pharma (ISIS)

Large drug coming through which would make them profitable in next 2 years. It is in stage 3 and it is a cholesterol drug which historically have an extremely high likelihood of getting approved once they have gotten to the final stage. Genetech is partnering with them and ABT is investing in them. They are the real deal.

The TIGER Biosensor equipment and an extensive pipeline of over fifteen new drugs make this a huge potential longterm winner. Best time to own a biotech is right before they become profitable. Get long and stay there.